Masaharu Fukami

Reduction of Serum Cholesterol Levels Alters Lesional Composition of Atherosclerotic Plaques

Masashi Shiomi, Takashi Ito, Toyohiro Tsukada et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 128 citations · Full text

Medicine, Cardiology, Pathology +17

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in - mice

Toshihiko Fujiwara, Mikiyo Wada, Kuniaki Fukuda et al. · Metabolism · 1991 · 116 citations

Medicine, Endocrinology, Pharmacology +17

The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats

Tomoyuki Fujioka, Futoshi Nara, Yoshio Tsujita et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1995 · 94 citations

Life Sciences, Biochemistry, Pharmacology +10

Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low

Masashi Shiomi, Takashi Ito, Yoshio Watanabe et al. · Atherosclerosis · 1990 · 58 citations

Veterinary Medicine, Endocrinology, Veterinary Pathology +9

Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits

Masaharu Fukami, Naoyuki Maeda, Junichiroh Fukushige et al. · Research in Experimental Medicine · 1993 · 58 citations

Life Sciences, Biochemistry, Physiology +11